Eight numbers in the abstract
Where each one falls
Only randomized results vote
Where it lands on the map
the abstract, start to end
… (acute coronary syndrome: relative risk, 0.74; 95% CI, 0.58-0.96; stroke: relative risk, 0.74; 95% CI, 0.59-0.94; revascularization: relative risk, 0.51; 95% CI, 0.37-0.72).
… of niacin with CVD mortality (RR, 0.98; 95% CI, 0.90-1.07) or coronary …
… of niacin treatment with stroke (RR, 0.95; 95% CI, 0.85-1.06), acute …
… a 26% reduction in stroke events (RR, 0.74; 95% CI, 0.59-0.94) in the …
… was associated with reduced risk (RR, 0.79; 95% CI, 0.64-0.98) for both …
… associated with a 26% lower rate (RR, 0.74; 95% CI, 0.58-0.96) compared …
← favours treatmentfavours comparator →
could be chanceCardiovascular events
RR 0.740.59–0.94
Cardiovascular events
RR 0.740.58–0.96
Cardiovascular events
RR 0.510.37–0.72
All-cause mortality
RR 0.980.90–1.07
Cardiovascular events
RR 0.950.85–1.06
Cardiovascular events
RR 0.740.59–0.94
Cardiovascular events
RR 0.790.64–0.98
Cardiovascular events
RR 0.740.58–0.96
Other lipid agentsCardiovascular eventsAll-cause mortality
1 / 4